Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids
Michelle Leech(Monash Institute of Medical Research), Eric F. Morand(Novartis (Switzerland)), Pamela Hall(Monash University), Stephen R. Holdsworth(University of Auckland), Helen Weedon(Repatriation General Hospital), Christine N. Metz(Northwell Health), Paul Hutchinson(National University of Singapore), Katerina Gianis(Monash Medical Centre), Richard Bucala, Malcolm Smith(Repatriation General Hospital)
Cited by 308
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
MIF Signal Transduction Initiated by Binding to CD74
|The Journal of Experimental Medicine|2003|1.1k
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
|The Journal of Immunology|2001|957
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728